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iinimal access ablation of atrial fibrillation (AF) has un-
dergone a progression. As our experience has grown,
he lesion set has progressed from simple pulmonary vein
PV) isolation to a more comprehensive lesion set, which can
e placed epicardially, and more closely replicates the left
trial lesions of the Cox maze III. Access has progressed from
ilateral mini thoracotomies initially described by Wolf and
oworkers,1 to a totally thorascopic approach highly modi-
ed from that initially described by Puskas and coworkers2
nd Yilmaz and coworkers.3
In our initial approach, 74 patients (46 paroxysmal, 14
ersistent, 14 longstanding persistent) underwent bilateral
V antral electrical isolation using a bipolar radiofrequency
lamp. (Groups were defined as follows: paroxysmal was
efined as recurrent AF that terminates spontaneously
ithin 7 days; persistent AF was defined as AF sustained
eyond 7 days, or lasting less than 7 days but requiring
ither pharmacologic or electrical cardioversion; long-
tanding persistent AF was continuous AF of greater than
-year duration.) Of the 74 patients, 13 had undergone
ne prior ablation, six had two prior ablations, and one
atient had three prior ablations. Fifteen of the 74 had
ermanent pacemakers in place. All patients underwent
ransesophageal echocardiograms on the table before the
rocedure, and those who had undergone a prior catheter
blation had a left atrial magnetic resonance imaging or
eft atrial computed tomographic scan.
Rhythm was monitored by office electrocardiography
ECG) at 1, 3, and 6 months. At 6 months, the burden of
F was assessed by a 14- to 21-day auto-triggered event
onitor. When patient circumstances dictated, a 24-hour
olter monitor was substituted for the 21-day event mon-
tor. The long-term monitors used sampled the rhythm at
5-second intervals. When AF was detected by irregular
hythm, a single 15-second rhythm strip was recorded.
he Heart Hospital, Baylor, Plano, Texas.
ames R. Edgerton reports receiving speaker and consultant fees from
Atricure.
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doi:10.1053/j.optechstcvs.2009.05.003nother rhythm strip was not recorded during that epi-
ode. Accordingly, we counted the number of episodes of
F but were unable to determine the duration of episodes
ver 15 seconds or the true burden of AF. Patients with
acemakers underwent pacemaker interrogation for epi-
odes of AF (Table 1).
One might expect that PV antral isolation and partial
utonomic denervation would not be adequate treatment
or patients in persistent and longstanding persistent AF
ecause of the associated changes in the left atrial sub-
trate, which occur in these conditions.4 This electrical
emodeling of the left atrium results in a fixed shortened
efractory period and a shortened fibrillatory interval.5
assive mechanical stretch of the left atrium that occurs in
his chronic condition can in itself be arrythmogenic.6,7
trial fibrosis has also been associated with AF.8,9 There-
ore, it is likely that isolating the PV triggers alone is in-
ufficient treatment for persistent and longstanding per-
istent AF. Hence, a more extensive lesion set similar to the
eft-sided Cox maze III is necessary.
To accomplish a lesion set replicating the left-sided Cox
aze III lesion set, a connecting lesion would need to be
dded between the left- and right-sided PVs, a connecting
esion to the base of the atrial appendage, and a connecting
esion to the mitral valve annulus. Traditionally, these
onnecting lesions are placed endocardially between the
eft and right inferior PVs, and from the right inferior PV
own to the mitral valve annulus crossing the left atrial
sthmus. However, when the epicardium is approached in
minimally invasive fashion, there are three inhibitors to
lacing the lesions in these locations. First, with currently
vailable techniques, there is little to no visualization af-
ordable posteriorly behind the left atrium. Second, as the
ircumflex coronary artery frequently overlies the mitral
alve annulus, there is significant risk for collateral dam-
ge to this vital structure. Finally, the epicardial landmark
or the mitral annulus is the coronary sinus. However, it
as been shown10 that the coronary sinus can be up to 13
m away from the mitral valve annulus, thus risking an
ncomplete connection which may result in left atrial flut-
er.
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Total thorascopic ablation of AF 225However, in the minimally invasive approach, we can ob-
ain excellent visualization through the transverse sinus be-
ind the aorta and the pulmonary artery. Therefore, we have
onceived of and developed a lesion set (the Dallas Lesion
et) that places all of the connecting lesions on the dome of
he atrium (Fig. 1). By working behind the superior vena cava
nd through the transverse sinus, we can place a transverse
onnecting lesion across the dome of the left atrium connect-
ng the right superior PV with the left superior PV. It is then
nly a short extension of this line on the left side that con-
ects it to the base of the left atrial appendage. The connect-
ng lesion to the mitral valve annulus can also be accom-
lished on the dome of the left atrium within the transverse
inus. The left fibrous trigone touches the mitral valve annu-
us and connects it to the aorta at the aortic root. The left
brous trigone meets the aortic valve at a point where the left
oronary cusp and the noncoronary cusp join. Therefore,
ith good visualization, we can place this connecting lesion
rom the left fibrous trigone at the anterior mitral valve an-
ulus, across the anterior dome of the atrium, and touching
ransverse dome line. This then replicates all of the left atrial
esions of the classic Cox maze III operation. Another short
inear lesion connecting the left superior pulmonary vein to
he left fibrous trigone then constructs a closed triangle on
able 1 Outcomes of Ablation in Initial Series of 74 Patients
Follow-Up
Paroxysmal Atrial Fibrillation Pa
(N  46)
EKG (N  43)
Holter/PM Interro
Event Monitor (N
NSR NSR
Months 43 (100.0%) 36 (83.7%)
Months off AAD 33 (76.7%) 30 (69.8%)
KG, electrocardiogram; PM, pacemaker; NSR, normal sinus rhythmhe dome of the atrium. By sensing and pacing within this triangle, one can test for entrance and exit block, thus dem-
nstrating acute conduction block of all the dome lesions.
igure 2 shows the surgical approach to the transverse sinus,
hich is further detailed in the diagrams that follow.
Twenty-nine patients (10 persistent, 19 longstanding per-
istent) were operated on using the Dallas Extended Lesion
et with intraoperative mapping for confirmation of block.
hemedian left atrial size was 5.4 cm. Follow-up at 6months
as with 2-week event monitor (20/29), pacemaker interro-
ation (8/29), or ECG (1/29). At 6 months 23/29 (79.3%)
ere free of atrial fibrillation. The patient who had only ECG
ollow-up was in AF on ECG and refused a longer term mon-
tor.
Only one of the patients failed as persistent AF. The others
ho failed, all failed as paroxysmal with a low residual bur-
en of AF and were asymptomatic. Of the 6 failures, two
atients had 1 episode, one patient had 2 episodes, one pa-
ient had 4 episodes, one patient had 6 episodes, and one had
CG alone for an undetermined number of episodes. All of
hese were “symptomatic successes.” The other failure had
50 episodes of continuous AF.
Early results with a minimally invasive extended linear
esion set suggest increased efficacy over pulmonary vein
solation for patients with persistent and longstanding persis-
s Persistent/Longstanding Persistent Atrial
Fibrillation Patients (N  28)
n/
) EKG (N  27)
Holter/PM Interrogation/Event
Monitor (N  23)
NSR NSR
22 (81.5%) 13 (56.5%)
13 (48.1%) 8 (34.8%)
, antiarrhythmic drugs.tient
gatio
 43ent atrial fibrillation.
226 J.R. EdgertonFigure 1 The Dallas Lesion Set. SVC  superior vena cava; v.  vein.
Total thorascopic ablation of AF 227Figure 2 Plane of access for left and right ablation on atrial dome in transverse sinus.
228 J.R. EdgertonOperative Technique
Figure 3 (A) Proper positioning of the patient in the operating room is critical to obtaining a successful surgical result.
The surgeon must have free access to the posterior axillary line bilaterally. Additionally, the use of long thorascopic
instrumentation means that the arm must be out of the way so that the instruments can be maneuvered in multiple
different planes. Initially, we tried positioning the arm up over the forehead; however, we found that the upper armwas
continually in the way, inhibiting movement of the long instruments.
To gain access to the posterolateral thorax and have the arms out of the way of instrumentation, we elevate the thorax
of the patient on three to five bath blankets. The arms are then placed on slightly padded arm boards on each side of
the operating table. The patient is prepped and draped so that the surgeon has access to the entire lateral thorax
bilaterally, the sternum, and both groin areas in case they should be needed for urgent access.
External defibrillator pads are placed behind the right shoulder and on the left flank. If sterile defibrillator pads are
available, one can be placed over the sternum and one directly posterior on the back of the patient.
Total thorascopic ablation of AF 229Figure 3 (Continued) (B, C) We perform the operation with three ports. Starting on the right side, a 5-mm port is
introduced in the mid-axillary line in the third intercostal space. CO2 insufflation expands the field and depresses the
diaphragm. Using a 30-degree scope, one can obtain good visualization throughout the thorax once absorptive
atelectasis of the lung has taken place.
The two other ports placed are both 10-mm ports. One is placed in the mid-clavicular line in approximately the
second intercostal space and the other in the mid-axillary line in approximately the seventh intercostal space. Both of
these ports are placed so that instruments passed through them can access the transverse sinus, behind the superior
vena cava and immediately cephalad to the right atrial appendage. This spot can actually be seen “through the
pericardium” with a 5-mm scope. To determine the exact placement of the 10-mm port sites, a spinal needle is passed
through the chest wall with the tip targeting the transverse sinus. Its position on the chest wall is changed until the site
of best access is determined. Once the optimal site for these ports is determined, a 15-mm incision is placed and the
10-mm ports are advanced. Because multiple instrument changes will be made through these port sites, and because
insufflation of CO2 in the chest is critical to maintain proper visualization, 0-silk sutures with a Red Rubber Robinson
tourniquet are placed around each of these port sites. Then when the ports are later removed to allow introduction of
other various sized instruments, the tourniquet can be run down to maintain the insufflation pressure within the
thorax. (C) Left side where all ports are placed more posteriorly.
230 J.R. Edgerton
4pulmonary vein; RPA  right pulmonary artery; RSPV  right superior pulmonary vein.
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Figure 4 (A)Working through these port sites, the right pericardium is open from the diaphragm to the level of the aorta
approximately 2 cm anterior to the phrenic nerve. Great care is taken at all times to not stretch the phrenic nerve.
Pericardial retraction sutures are placed utilizing an automatic suturing device and brought out through the postero-
lateral chest wall. Then using two blunt instruments, the fibroareolar tissue between the inferior vena cava and the right
inferior pulmonary vein is dissected away until there is a wide opening into the posterior pericardium.
(B) Attention is then directed to the space between the right superior pulmonary vein, the right pulmonary artery,
and the superior vena cava. The pericardium is bluntly and sharply dissected away until a portion of the superior vena
cava is converted to intrapericardial. Then using a suction irrigator for retraction in the left hand and an L cautery device
in the right hand, the tissue between the superior vena cava and the right pulmonary artery are divided along the entire
course of the superior vena cava. Having thus surrounded the superior vena cava, one should be able to elevate it and
see through the transverse sinus with a 5-mm scope.
The visceral pericardium surrounds the superior vena cava and behind it inserts onto the muscular dome of the left
atrium. Behind the superior vena cava, between the two leafs of investing pericardium as they insert on the dome of the
left atrium, there is always a very well-established fat pad behind the superior vena cava and in front of the left atrial
muscular dome. This fat pad must be dissected away so that the ablation devices can get down to the muscular dome
of the atrium. Fat is a relative insulator to radiofrequency energy. If one tries to burn through this fat, this is a common
site of a gap in the ablation line leading to a failure of the procedure. Accordingly, it is critical that this fat pad be
dissected until the operator can see the muscular dome of the left atrium. a. artery; IVC  inferior vena cava; n. Figure 5 At this point, the 10-mm port that is in the most caudad site is removed. The lighted dissector (AtriCure,
Cincinnati, OH)will not fit through the 10-mmport but will easily slide through the port site. Once it is introduced into
the chest, the skin tourniquet is run down to reestablish the CO2 pressure within the chest and ensure ongoing
exposure and visualization. This lighted dissector is advanced through the space between the right inferior pulmonary
vein and the inferior vena cava into the posterior pericardium. Then by slowly and carefully articulating the clamp, the
lighted blunt tip is dissected through the space between the right pulmonary artery and the right superior pulmonary
vein. The clear plastic sheath is pulled off of the dissector and the lighted dissector is withdrawn. RIPV right inferiornerve; SVC  superior vena cava; v.  vein.
232 J.R. EdgertonFigure 6 This clear plastic tape is merely a leader, the other end of which attaches to the posterior jaw of a bipolar
radiofrequency ablation clamp (AtriCure).
At this point, a sensing pen is passed through the most cephalad port site and used to obtain a baseline electrogram
on multiple sites on both the superior and the inferior pulmonary veins. These baseline electrograms should show
transmitted electrical activity from the atrium. After the ablation lines have been placed, the electrograms in the
pulmonary veins are again obtained and this time the absence of transmitted electrical activity from the atrium indicates
acute entrance block has been obtained. Alternatively, if the patient is in sinus rhythm, one can pace in the pulmonary
veins and look for exit block.
The pen is also utilized to deliver high-frequency stimulation to locate the presence of active ganglionated plexi.
These are located by uncovering the bradycardic response (greater than 50% increase in R-to-R interval in response that
occurs when one stimulates right over a ganglionated plexi).11
The closed bipolar clamp is then introduced through the most-caudad port site and the tourniquet is again snuggled
around the shaft of the clamp to reestablish the pneumothorax. By pulling the clear plastic tape up and out through the
second intercostal space port site, the posterior jaw of the clamp is then delivered behind the right-sided pulmonary
veins. It is manipulated until the jaws are well up on the antrum of the pulmonary vein and well away from the
bifurcation of the pulmonary veins. Three to five firings of the clamp are then done to produce an ablation line on the
right pulmonary vein antrum.
After the ablation lines are completed with the clamp, the pen is again utilized to test in areas that were previously
positive. If they are still positive, indicating they were not ablated with the clamp, this same sensing pen is utilized to
deliver radiofrequency energy performing further ablation until all the areas that were positive for ganglionated plexi
are now negative. RIPV  right inferior pulmonary vein; RSPV  right superior pulmonary vein.
Total thorascopic ablation of AF 233Figure 7 The internally cooled, linear bipolar radiofrequency device is now introduced through the most caudad port
site. This device (Cooled Rails; AtriCure) has a deflectable tip and a malleable shaft. Now that the fat pad behind the
superior vena cava has been divided, one can clearly see the muscular dome of the left atrium when the superior vena
cava is elevated. The linear bipolar ablation device is positioned behind the superior vena cava. It is utilized to make a
linear burn from the right superior pulmonary vein across the dome of the left atrium pointing toward the left superior
pulmonary vein. In most cases when looking through the transverse sinus, the left superior pulmonary vein and even
left atrial appendage can easily be visualized through this approach. This ablation line from the right superior
pulmonary vein toward the left superior pulmonary vein is placed as posteriorly on the dome of the atrium as possible.
Sometimes fibroareolar connective tissue between the atrial dome and the right pulmonary artery must be divided to
allow this posterior placement of this ablation line. LSPV  left superior pulmonary vein; RPA  right pulmonary
artery; RSPV  right superior pulmonary vein; SVC  superior vena cava.
234 J.R. EdgertonFigure 8 The tip of this same ablation device is now articulated to the right and further bending of the malleable shaft
is done if possible. The tip is positioned at the junction of the noncoronary cusp and the left coronary cusp of the aorta.
This juncture as well as the left main coronary can usually be easily visualized by placing the 30-degree 5-mm scope
behind the superior vena cava and into the transverse sinus. The operator will see that the left main coronary artery is
2 to 3 cm away from the site of this ablation. Confirmation of the location of the tip of the ablation device can be done
by looking at the transesophageal echo. Utilizing the mid-esophageal, long access, 140-degree view, the left fibrous
trigone where the aortic annulus touches the mitral annulus can easily be visualized. Slight wiggling of the ablation
device produces movement that is readily apparent on the echo view when the device is in the proper position. A lesion
is then burned from the fibrous trigone obliquely on the dome so that it connects the left fibrous trigone to the
transverse ablation line across the dome of the atrium. This linear ablation line can be touched up by using the bipolar
pen to also deliver radiofrequency ablation lesions in a “stamping” fashion.
This completes the lesions that are placed from the right thorascopic approach. The pericardium is then closed, and
a long catheter (I-Flow Corporation, Lake Forest, CA) to continuously infuse Marcaine is tunneled beneath the pleura
to bathe all the intercostal nerves. A 19-French silastic chest tube is placed. The ports are withdrawn; the lung is
inflated, and all the wounds closed. a.  artery; RPA  right pulmonary artery.
Total thorascopic ablation of AF 235Figure 9 Next the left side is approached. The approach is similar to the right side but somewhat more posterior.
The 5-mm camera port is placed in the third intercostal space between the mid axillary line and the posterior
axillary line and CO2 is insufflated. Again, spinal needles are advanced through the chest to determine the exact
positioning of the other two ports so that their site will afford access to the left atrial appendage and the transverse
sinus. Usually, the cephalad port is in the midclavicular line at approximately the second intercostal space and the
caudad port is in the sixth or seventh intercostal space at the posterior axillary line.
236 J.R. EdgertonFigure 10 Working through these ports, the pericardium is opened. However, on the left side, the opening to the
pericardium is done posterior to the phrenic nerve. Great caremust be taken to avoid injury to the phrenic nerve.When
extending the incision cephalad, caremust also be taken not to injure the recurrent laryngeal nerve as it courses beneath
the aorta. To protect the phrenic nerve, a single suture is placed in the anterior leaf of the pericardium, just posterior
to the phrenic nerve, and this is brought out through the anterior chest wall. This lifts the phrenic nerve out of the field
and also helps to expose the atrial appendage. LIPV left inferior pulmonary vein; LPA left pulmonary artery; LSPV left
superior pulmonary vein; n. nerve.
Total thorascopic ablation of AF 237Figure 11 Working through these ports, one should be able to visualize into the transverse sinus and see the lesions that
were placed from the right side. The sensing pen is placed and baseline electrograms in the pulmonary veins are
recorded. Then high-frequency stimulation is performed to locate any active ganglionated plexi and their positions are
noted. Following this, the ligament of Marshall is divided all the way posterior.
Thereafter, the lighted dissector is introduced from the most caudad port site and directed around the
pulmonary veins with the tip coming up at the point of the divided ligament of Marshall. LIPV  left inferior
pulmonary vein; LPA  left pulmonary artery; LSPV  left superior pulmonary vein.
238 J.R. EdgertonFigure 12 The bipolar radiofrequency clamp is then introduced through the most caudad port site. Using the guide that
was attached to the lighted dissector, the posterior jaw is introduced behind the pulmonary vein and the clamp is closed
well up on the pulmonary vein antrum where three separate firings are performed, changing the position of the clamp
each time. The clamp is withdrawn and the pen is again introduced. Sensing in the pulmonary veins should now show
electrical silence, indicating entrance block so that no atrial electrical activity is transmitted into the veins. Alternatively,
if the patient is in sinus rhythm, one can pace in the pulmonary veins and look for exit block. Finally, the pen is used
to stimulate in any areas where active ganglionated plexi were previously located. If these sites have not been ablated
by the application of the radiofrequency clamp, they are now ablated by applying radiofrequency energy through the
pen device. LIPV left inferior pulmonary vein; LPA left pulmonary artery; LSPV left superior pulmonary vein.
Total thorascopic ablation of AF 239Figure 13 The clamp is withdrawn and the linear radiofrequency ablation device is introduced through the most caudad
port site. The atrial appendage and the pulmonary artery are retracted to open up visualization into the transverse sinus.
One can readily see the dome line coming across from the right side as it is aimed toward the left superior pulmonary
vein. The linear ablation device is now used to complete this dome line so that it connects the right superior pulmonary
vein over to the left superior pulmonary vein as far posteriorly as can be done in a transverse sinus.
The malleable linear ablation device is now articulated to the left and bent to the left. Another ablation line is placed
from the left fibrous trigone to the right superior pulmonary vein. LOM Ligament of Marshall; LPA left pulmonary
artery; LSPV  left superior pulmonary vein.
240 J.R. EdgertonFigure 14 With the ablations that have been done on the dome, an inverted triangle has now been constructed. The
sensing pen is placed into the triangle. If each of these ablation lines is transmural, then there will be no conducted atrial
activity into this triangle and the recorded electrogram will be flat. Alternatively, if the patient is in sinus rhythm, one
can pace in this triangle and look for exit block to confirm that acute block has been obtained.
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Total thorascopic ablation of AF 241onclusions
he multiple burns that have been done usually result in
roducing an effusive pericarditis. To limit this and allow
arly removal of the pleural catheters, all patients are started
n steroids in the operating room and continued on an oral
orm for 3 to 5 days postoperatively. All preoperative medi-
ations, including antiarrhythmics, are reinstated. Unless
ontraindicated, coumadin is started on all patients and the
osing is refined as an outpatient. Most patients are dis-
harged on the third postoperative day. Patients are seen at 1,
, and 6 months postoperatively. The 1-month visit is for
ound checks. At the 3-month visit a 24-hourHolter is done.
f the Holter shows no atrial fibrillation, atrial tachycardia,
nd no atrial flutter, and the patient reports no episodes of the
ame, the antiarrhythmic medications are discontinued. At
he 6-month visit, a 2-week monitor is done. If the 2-week
onitor shows no atrial fibrillation, atrial tachycardia, and no
Figure 15 Finally, a stapling device is introduced through
base of the atrial appendage. Using the transesophageal
base of the atrial appendage and it is amputated. The a
infusion catheter is then threaded subpleural from cauda
all the intercostal nerve roots. The pericardium is reappr
the wounds are closed in layers. Sterile dressings are app
and transferred to the postoperative care ward.trial flutter, the coumadin is discontinued unless it is spe-ifically indicated for another reason. A 2-week monitor is
one at 1 year postoperatively and at 12-month intervals
hereafter for life. If the patient has any recurrence of atrial
ysrhythmia, he is referred for full electrophysiological study
n the electrophysiologic laboratory.
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